Key Highlights
- Hardide said full-year results for the year to 30 September 2026 will be materially ahead of market expectations.
- Third-quarter Revenue reached £4.1m, taking nine-month revenue to £8.9m.
- The board now expects to double annual revenue in FY2026, well ahead of its original schedule.
- A £4.5m Investment in three new coating reactors was approved, expected to come on stream in late FY2027.
- Roughly 50% of FY2027 tungsten gas Supply requirements have been secured through supply-chain diversification.
Hardide (LSE:HDD), the AIM-quoted advanced surface-coatings specialist, delivered an unambiguously upbeat trading update on 22 July 2026, telling investors that full-year results for the year ending 30 September 2026 would be materially ahead of market forecasts. Third-quarter revenue reached £4.1m, taking the nine-month total to £8.9m, and the board now expects to double annual revenue well ahead of its original schedule. Margins are running better than anticipated, and the company approved a £4.5m investment in three new coating reactors. Yet the shares fell on the news. For a thinly traded micro-cap that had already enjoyed a strong run in 2026, the pullback looks more like profit-taking and illiquidity than a verdict on the business. The precise catalyst for the single-session decline is not clearly established, and investors should weigh the operational momentum against the stock's volatility.
What happened?
On 22 July 2026 Hardide issued a trading update covering its financial year to 30 September 2026, and the message was strikingly positive. The company said full-year performance would be materially ahead of market expectations, driven by new contract wins, better factory utilisation and operating margins running higher than anticipated.
Third-quarter revenue, for the three months to 30 June 2026, came in at £4.1m, lifting nine-month revenue to £8.9m. Against a previous full-year forecast of £13.4m of revenue and £4.3m of EBITDA, the board now expects to double annual revenue in the current financial year, well ahead of its original timetable, and to more than double revenues again over the next two to three years.
Alongside the upgrade, Hardide approved a £4.5m investment in three new coating reactors and supporting infrastructure, to be funded through internal cash resources and borrowings as needed, with the new capacity expected to come on stream in late FY2027.
Despite the strength of the statement, the shares fell. For a lightly traded AIM micro-cap that had already run up sharply during 2026, the decline sits awkwardly against the fundamentals — and no clear single catalyst for the drop was evident, making profit-taking and thin Liquidity the most likely explanations.
The numbers investors need to know
Hardide is a small company, so the numbers are modest in absolute terms but show a steep growth trajectory.
- Q3 (three months to 30 June 2026) revenue: £4.1m.
- Nine-month revenue: £8.9m.
- Previous full-year forecast: £13.4m revenue and £4.3m EBITDA — now expected to be exceeded materially.
- Guidance: doubling of annual revenue in FY2026, well ahead of original schedule.
- Capital investment: £4.5m for three new coating reactors and infrastructure, operational in late FY2027, funded from internal cash and borrowings as needed.
- Supply chain: tungsten gas supply diversified, with roughly 50% of FY2027 requirements secured.
- Board change: Dr Yuri Zhuk moves from Technical Director to Chief Technology Officer from 1 October 2026, stepping down as a company director.
Why the market may be concerned
The most honest reading is that the sell-off is hard to pin on the fundamentals, which were strong. For a micro-cap of this size, share-price moves on any given day are frequently dominated by liquidity rather than news: a single seller can move the price, and after a strong run in 2026 some holders may simply have banked gains on the good news.
That said, there are legitimate points for caution. The £4.5m reactor investment is large relative to Hardide's scale and is to be funded partly through borrowings. For a company that has historically operated with a tight balance sheet, taking on Debt to expand capacity introduces execution and financing risk, and the new reactors will not contribute revenue until late FY2027.
There is also customer-concentration and end-market risk. Hardide's coatings serve cyclical sectors including energy, aerospace and defence, with a growing semiconductor pipeline. A reliance on a limited number of large contracts means that timing slippage or the loss of a key account could swing results. Finally, the sheer pace of the guided revenue doubling raises the bar for delivery — any hint of a stumble against elevated expectations could be punished.
Why bulls may see an opportunity
For bulls, the update is exactly what a growth micro-cap is supposed to deliver: rapid revenue expansion, margins beating expectations, and management confident enough to invest ahead of demand. Doubling revenue in a single year, well ahead of schedule, is a powerful signal that Hardide's coatings are winning genuine commercial traction.
The £4.5m capacity investment, rather than being a worry, can be read as a statement of confidence. Adding three new reactors positions Hardide to more than double revenues again over the next two to three years, targeting Diversification across new customers, the Middle East and emerging sectors such as semiconductors. Committing capital to capacity is what companies do when order books are filling faster than they can supply.
Operational de-risking is also under way. By diversifying its tungsten gas supply and securing around half of its FY2027 requirements, Hardide has improved cost visibility and reduced a key input risk. Combined with better-than-expected margins, that points to a Business becoming more resilient as it scales. For investors who can tolerate the Volatility of a small AIM stock, a pullback on good news can be the more attractive entry point.
What happens next?
The immediate milestone is the full-year results for the year ended 30 September 2026, which will confirm whether Hardide delivered the promised material improvement and revenue doubling. Investors will look for the actual EBITDA outcome against the previous £4.3m forecast and for detail on cash generation and net debt after the capacity commitment.
Longer term, attention turns to execution of the £4.5m expansion. The three new reactors are due on stream in late FY2027, so updates on installation progress, funding mix and the ramp of new contracts — particularly in semiconductors and the Middle East — will shape the multi-year growth case.
Given the micro-cap's thin liquidity, near-term share-price swings may remain disconnected from the fundamentals. The key question is whether Hardide can convert its accelerating order book into sustained, cash-generative growth without straining a small balance sheet.
Bottom line
Hardide (LSE:HDD)'s 22 July update was about as good as a small growth company can offer: full-year results guided materially ahead, nine-month revenue of £8.9m, margins beating plan and a £4.5m capacity investment to support a doubling of revenue and more to come. The share-price drop on that news is difficult to reconcile with the fundamentals and most plausibly reflects profit-taking and the thin liquidity typical of an AIM micro-cap after a strong 2026 run, rather than any deterioration in the business. The precise trigger for the single-session fall is not clearly established. The genuine risks — funding the expansion partly with debt, delivering against raised expectations, and dependence on cyclical, contract-driven end-markets — are real but familiar for a company of this size. On the evidence of this update, Hardide's operational momentum is strengthening; the volatility is the price of admission.



_11_18_2026_13_53_59_733490.jpg)


Please wait processing your request...